Prospects for herpesvirus vaccination--safety and efficacy considerations.
D006564:Herpesviridae / Q000276:immunology*; D006566:Herpesviridae Infections / Q000517:prevention & control*; D006801:Humans; D014481:United States; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated; D014765:Viral Vaccines
D014613:Vaccines, Attenuated; D014765:Viral Vaccines